NO841540L - Fremgangsmaate ved fremstilling av bredspektrede influensaantisera - Google Patents

Fremgangsmaate ved fremstilling av bredspektrede influensaantisera

Info

Publication number
NO841540L
NO841540L NO841540A NO841540A NO841540L NO 841540 L NO841540 L NO 841540L NO 841540 A NO841540 A NO 841540A NO 841540 A NO841540 A NO 841540A NO 841540 L NO841540 L NO 841540L
Authority
NO
Norway
Prior art keywords
influense
antization
procedure
specific
manufacturing wide
Prior art date
Application number
NO841540A
Other languages
English (en)
Other versions
NO161002B (no
NO161002C (no
Inventor
Nicola Green
Stephen Alexander
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO841540L publication Critical patent/NO841540L/no
Publication of NO161002B publication Critical patent/NO161002B/no
Publication of NO161002C publication Critical patent/NO161002C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO841540A 1982-08-23 1984-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider. NO161002C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
PCT/US1983/001291 WO1984000687A1 (en) 1982-08-23 1983-08-23 Broad spectrum influenza antisera

Publications (3)

Publication Number Publication Date
NO841540L true NO841540L (no) 1984-04-17
NO161002B NO161002B (no) 1989-03-13
NO161002C NO161002C (no) 1989-06-21

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841540A NO161002C (no) 1982-08-23 1984-04-17 Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.

Country Status (16)

Country Link
EP (1) EP0116629A4 (no)
JP (1) JPS59501714A (no)
KR (1) KR840006198A (no)
AU (1) AU570929B2 (no)
DK (1) DK203684D0 (no)
ES (1) ES8505819A1 (no)
FI (1) FI841583A (no)
GR (1) GR78931B (no)
IL (1) IL69556A (no)
IT (1) IT1168636B (no)
NO (1) NO161002C (no)
NZ (2) NZ220612A (no)
PH (1) PH18872A (no)
PT (1) PT77230B (no)
WO (1) WO1984000687A1 (no)
ZA (1) ZA836080B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
KR910700259A (ko) * 1989-01-12 1991-03-14 리차드 이. 림바크 T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
JP2996864B2 (ja) * 1994-03-30 2000-01-11 寳酒造株式会社 抗体可変領域dna
EP2024393A2 (en) * 2006-05-15 2009-02-18 Sea Lane Biotechnologies,llc. Neutralizing antibodies to influenza viruses
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
KR101485197B1 (ko) * 2006-09-07 2015-01-23 크루셀 홀란드 비.브이. 인플루엔자 바이러스 h5n1을 중화시킬 수 있는 인간 결합분자 및 그것의 용도
ITTO20070066A1 (it) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc Anticorpi monoclonali anti-idiotipo mimotopi dell'antigene gp 120 di hiv
US8114967B2 (en) 2007-03-27 2012-02-14 Sea Lane Biotechnologies Llc Constructs and libraries comprising antibody surrogate light chain sequences
ITTO20080204A1 (it) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
WO2009121004A2 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
ITTO20080398A1 (it) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
ITTO20080964A1 (it) 2008-12-22 2010-06-23 Natimab Therapeutics S R L Anticorpo monoclonale anti-hcv come medicamento per il trattamento terapeutico e la prevenzione di infezioni da hcv
JP5780762B2 (ja) 2008-12-25 2015-09-16 国立大学法人大阪大学 抗ヒトインフルエンザウイルス・ヒト型抗体
US9051359B2 (en) 2009-03-30 2015-06-09 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
CN102482345A (zh) * 2009-05-13 2012-05-30 航道生物技术有限责任公司 针对流感病毒的中和分子
CA2800182A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
IT1395961B1 (it) * 2009-06-01 2012-11-02 Pomona Biotechnologies Llc Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
BR112012020839A2 (pt) * 2010-02-18 2017-11-21 Sinai School Medicine vacinas para uso na profilaxe e tratamento de doença de vírus da influenza
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
EP2736928B1 (en) 2011-07-28 2019-01-09 i2 Pharmaceuticals, Inc. Sur-binding proteins against erbb3
EA201490659A1 (ru) 2011-09-20 2014-11-28 Маунт Синай Скул Оф Медсин Вакцины против вируса гриппа и их применения
EP3446707A1 (en) 2011-12-22 2019-02-27 i2 Pharmaceuticals, Inc. Surrogate binding proteins
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
AU2013362935B2 (en) 2012-12-18 2018-10-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
WO2016118937A1 (en) 2015-01-23 2016-07-28 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
MX2018015755A (es) 2016-06-15 2019-08-29 Icahn School Med Mount Sinai Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
EP3606555A4 (en) 2017-04-07 2021-08-04 Icahn School of Medicine at Mount Sinai INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
CN113924147A (zh) 2019-03-25 2022-01-11 威特拉公司 用于治疗和预防流感的组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom

Also Published As

Publication number Publication date
NZ220612A (en) 1988-07-28
IT8348868A0 (it) 1983-08-22
ES525088A0 (es) 1985-06-16
PT77230B (en) 1986-02-04
DK203684A (da) 1984-04-18
PH18872A (en) 1985-10-21
EP0116629A1 (en) 1984-08-29
FI841583A0 (fi) 1984-04-19
ZA836080B (en) 1984-04-25
JPS59501714A (ja) 1984-10-11
AU570929B2 (en) 1988-03-31
IL69556A (en) 1988-05-31
ES8505819A1 (es) 1985-06-16
IL69556A0 (en) 1983-11-30
IT1168636B (it) 1987-05-20
GR78931B (no) 1984-10-02
PT77230A (en) 1983-09-01
DK203684D0 (da) 1984-04-18
NZ205341A (en) 1988-07-28
NO161002B (no) 1989-03-13
KR840006198A (ko) 1984-11-22
EP0116629A4 (en) 1987-06-29
AU1947183A (en) 1984-03-07
FI841583A (fi) 1984-04-19
NO161002C (no) 1989-06-21
WO1984000687A1 (en) 1984-03-01

Similar Documents

Publication Publication Date Title
NO841540L (no) Fremgangsmaate ved fremstilling av bredspektrede influensaantisera
NO812977L (no) Fremgangsmaate for fremstilling av mikrokapsler
NO810506L (no) Fremgangsmaate ved fremstilling av polytetrafluoretylengjenstander
NO820222L (no) Fremgangsmaate for fremstilling av aromatiske uretaner
NO811330L (no) Fremgangsmaate ved fremstilling av mikroemulsjoner
NO792267L (no) Fremgangsmaate ved fremstilling av substituerte benzapiner
NO833914L (no) Fremgangsmaate ved fremstilling av hjul
NO813863L (no) Fremgangsmaate ved toerking av trevirke
NO154602C (no) Fremgangsmaate ved opparbeiding av vrakglass.
NO834661L (no) Fremgangsmaate ved fremstilling av modellis
NO831495L (no) Fremgangsmaate ved fremstilling av sulfatmasse
DK156099C (da) Fremgangsmaade ved fremkaldelse
NO810695L (no) Fremgangsmaate ved fremstilling av sementklinker.
NO161720C (no) Fremgangsmaate ved fremstilling av sponplater
NO830784L (no) Fremgangsmaate for fremstilling av tioetere
NO834407L (no) Fremgangsmaate ved delignifiserende bleking av cellulosemasse
FI831883L (fi) Process foer tillverkning av aromatiska polyestrar
NO150515C (no) Fremgangsmaate ved fremstilling av 5`-deoxy-5`-methylthioadenosin
NO802983L (no) Fremgangsmaate ved fremstilling av krympeartikler
FI833868A0 (fi) Anordning foer daempning av en slagbelastning
NO831445L (no) Fremgangsmaate for deemulgering ved hjelp av ammonium-polyamidoaminer
NO822485L (no) Fremgangsmaate ved fremstilling av bisykliske forbindelser
FI831814A0 (fi) Anordning foer bearbetning av traedbark
FI831781A0 (fi) Process foer portionsvis kokning av traeflis
NO833669L (no) Fremgangsmaate for elektroplettering